Evidence map›Paper›PMID 27402794›Full record

ArticleThe Biochemical journal2016

Structural and biophysical analysis of nuclease protein antibiotics.

Alexander Klein, Justyna Aleksandra Wojdyla, Amar Joshi, Inokentijs Josts, Laura C McCaughey, Nicholas G Housden, Renata Kaminska, Olwyn Byron, Daniel Walker, Colin Kleanthous

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Alexander KleinDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Justyna Aleksandra WojdylaDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K. Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland.
Amar JoshiDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Inokentijs JostsInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, U.K.
Laura C McCaugheyInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, U.K.
Nicholas G HousdenDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Renata KaminskaDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Olwyn ByronSchool of Life Sciences, University of Glasgow, University Place, Glasgow G12 8TA, U.K.
Daniel WalkerInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, U.K.
Colin KleanthousDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
University of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G020671/1Wellcome Trust 093592/Z/10/ZWellcome Trust 106064/Z/14/2
6 · The paper itself

Abstract

Protein antibiotics (bacteriocins) are a large and diverse family of multidomain toxins that kill specific Gram-negative bacteria during intraspecies competition for resources. Our understanding of the mechanism of import of such potent toxins has increased significantly in recent years, especially with the reporting of several structures of bacteriocin domains. Less well understood is the structural biochemistry of intact bacteriocins and how these compare across bacterial species. Here, we focus on endonuclease (DNase) bacteriocins that target the genomes of Escherichia coli and Pseudomonas aeruginosa, known as E-type colicins and S-type pyocins, respectively, bound to their specific immunity (Im) proteins. First, we report the 3.2 Å structure of the DNase colicin ColE9 in complex with its ultra-high affinity Im protein, Im9. In contrast with Im3, which when bound to the ribonuclease domain of the homologous colicin ColE3 makes contact with the translocation (T) domain of the toxin, we find that Im9 makes no such contact and only interactions with the ColE9 cytotoxic domain are observed. Second, we report small-angle X-ray scattering data for two S-type DNase pyocins, S2 and AP41, into which are fitted recently determined X-ray structures for isolated domains. We find that DNase pyocins and colicins are both highly elongated molecules, even though the order of their constituent domains differs. We discuss the implications of these architectural similarities and differences in the context of the translocation mechanism of protein antibiotics through the cell envelope of Gram-negative bacteria.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBiophysicsEndonucleasesProtein ConformationSequence Homology, Amino AcidAnti-Bacterial AgentsEndonucleasesbacteriocincolicincrystallographypyocinsmall-angle scattering

Identifiers

PMID27402794
PMCPMC5264503
OpenAlexW2471198927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.